TrialJournal of pediatric hematology/oncology2014

Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation.

Erin M Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.